Site under maintenance
Cohort Innovation Day
November 5 2025
Imagine Institute, Paris
Cohort Innovation Day (CID) is an international event aimed at fostering collaborations between researchers and economic players in the health sector. It provides a unique opportunity to showcase the potential of French cohorts to health companies, whether national or international, ranging from large industries to biotech firms.
For its 2025 edition, CID will take place on November 5th at Institut Imagine in Paris, organized by Ariis (Alliance for Research and Innovation in Health Industries), Medicen (the Health Competitiveness Cluster in Île-de-France), and Inserm.
The event will feature:
- Plenary sessions and round tables
- Presentations from participating cohorts
- Dedicated B2B meetings between companies and cohort representatives
CID offers cohort leaders the chance to connect with economic players, promote their cohorts, and explore new collaborations or strengthen existing ones.
Participating cohorts will be selected through this call for expressions of interest by a scientific committee composed of experts from both academic and private research sectors. Selected cohorts will be featured in the event catalog, participate in B2B meetings, and some will present during plenary sessions.
Cohort leaders wishing to participate are encouraged to submit their applications via the link below. Special attention will be given to cohorts focused on at least one of the following four key therapeutic areas:
- Immune and Inflammatory Diseases
- Metabolic and Cardiovascular Diseases
- Neurodegenerative Diseases
- Thromboembolic Diseases
However, outstanding cohorts from other fields may also be considered.
- Details
- Written by Super User
- Category: Info
Provisional schedule:
October 3rd, 2018 – Paris
| 9:00 am - 9:10 am |
Opening remarks: why France? - Yves LEVY, Chairman of Aviesan & Marc BONNEVILLE, Chairman of ARIIS |
| 9:10 am - 9:30 am |
21st century epidemiology: challenges and opportunities - Gilles BABINET, France’s Digital Champion for the European Commission |
| 9:30 am - 9:50 am |
The "Constances" cohort: design, applications and foresight - Marie ZINS, Scientific leader of Constances |
| 9:50 am - 10:45 am |
Round table 1 - AI for biomarker discovery: what can we truly expect ? - Stanley DURRLEMAN, Researcher, Inria & ICM Brain and Spine Institute - Xosé FERNANDEZ, Chief Data Officer, Curie Institute - Meriem SEFTA, Partnership and Translational Research Manager, Owkin - Benoit TYL, Director of Cardiovascular Translational Research, Servier - Nicolas VILLAIN, Head of Research in AI for Medical Imaging, Philips |
| 10:45 am - 11:00 am |
Practical case - From Paris to Boston: a "deep patient" in nephrology - Alexandre LOUPY, Nephrologist at the Department of Nephrology and Kidney Transplantation, Necker Hospital |
| 11:00 am - 11:30 am |
Coffee break - Networking |
| 11:30 am - 11:50 am |
An insight by a global industry - Human derived genome scale data sets and advances analytics to accelerate drug discovery - Philippe SANSEAU, Head of Computational Biology and Stats, GSK |
| 11:50 am - 12:45 am |
Round table 2 - Real-world data: a broad foresight on this tomorrows' gold standard - Michèle ARNOE, Head Growth and Innovation, IQVIA - Valérie EDEL, Vice-Director, Health data Institute - Marc FROUIN, Chief Operating Officer, BioSerenity - Ramon HERNANDEZ, Head of Advanced Analytics in R&D, Sanofi - Remy SLAMA, Scientific coordinator of the SEPAGES cohort (to be confirmed) |
| 12:45 am - 12:55 pm |
Overview of the rising French start-ups using AI on cohorts - Rosalie MAURISSE, Head of the health sector, Expertise Direction, BpiFrance |
| 12:55 pm - 1:15 pm |
Concluding remarks and insight from Israel - Ran BALICER, Founding Director, Clalit Research Institute of Israel
|
| 1:15 pm - 2:30 pm |
Lunch & Networking with start-ups [PRIVATE ACCESS - by invitation only] |
| 2:30 pm - 6:00 pm |
B2B meetings [PRIVATE ACCESS - by invitation only] |
- Details
- Written by Super User
- Category: Info
Organizing committee
Zeina ANTOUN, GSK
Vanessa BESSON-DUBOURG, INSERM TRANSFERT
Alice BOUSSELET, INSERM TRANSFERT
Mireille CARALP, INSERM TRANSFERT
Aurélie DEFAUX, ARIIS
Sylvain DURRLEMAN, Aviesan/ITMO Santé Publique
Marco FIORINI, ARIIS
Véronique FOUINAT, ARIIS
Jean-Marie GAGLIOLO, Aviesan/ITMO Santé Publique
Anne HAZIZA, ARIIS
Industrials members of steering committee
BATAMAN-ONAL Yasemin, Sanofi Pasteur
BEZIZ Dan, Lilly
CHEVALIER Marie-Pierre, Pfizer
DELONCA Jean, Shire
DUBOIS Frédéric, Servier
FAUCONNIER Laurence, Stago
JULLIAN Nathalie, Ipsen
LESAGE Sabrina, Pfizer
LONGIN Juliette, Merck
NACHBAUR Gaëlle, GSK
PETIT-NIVARD Jean-Frédéric, Roche
SALZMAN Valérie, Servier
THEVENON Julien, Janssen France / Johnson & Johnson
THOMAS-DELECOURT Florence, AstraZeneca
TIREL Anny, MSD